CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Nathaniel L. Baker

OPENALEX: A5055665031↗OPENALEX: A5128890541↗ORCID: 0000-0003-3313-1579↗

Affiliations

Organizations

Medical University of South Carolinaauthorship · US Ralph H. Johnson VA Medical Centerauthorship · US University of South Carolinaauthorship · US

Public evidence

2 connected articles

N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings.2025 · Europe PMC Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial.2023 · PubMed Central Open Access

Registered research

Connected studies

A Prospective Trial of Varenicline and Incentives for Tobacco Cessation in Adultsnct04228965 N-Acetylcysteine for Youth Cannabis Use Disordernct03055377

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Nathaniel L. Baker - Medical Cannabis Research Engine